The London-based Beazley Group plc announced yesterday that Chief Executive Andrew Beazley will have a reduced day-to-day involvement in the business in the coming months as he undergoes medical treatment of an undisclosed nature.

Beazley, a global firm which manages Lloyd's Syndicates 2623 and 623 and has aggregate underwriting capacity of ?860 million ($1.7 billion), said while Mr. Beazley is undergoing treatment, Nicholas Furlonge, co-founder of Beazley, will cover for the chief executive when required.

A spokesperson for the company, Amanda Lee, said no specifics on the nature of Mr. Beazley's condition are being released as it is a private matter. She noted that Mr. Furlonge has been working along side Mr. Beazley for the past 20 years.

Recommended For You

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more inforrmation visit Asset & Logo Licensing.